Status: Recruiting
A Study of NHL907 in Healthy Adult Participants
The goal of this study is to evaluate the safety, tolerability and pharmacokinetics of NHL907 when administered as multiple oral doses in healthy adult participants.
Participants needed: 64
Trial details
Phase: Phase 1Age: 18-60Biological sex: AllType: InterventionalSponsor: NeuHyll AUS Pty LtdUpdated: Jun 10, 2026Locations: 1
Eligibility criteria
Healthy adult male and female participants aged between 18 and 60 years of age,... [+7]
History or evidence of clinically significant disorders and deemed not suitable... [+27]